The University of Rochester Cancer Center (URCC), a research institute within the University of Rochester School of Medicine and Dentistry, proposes to continue serving as a research base for Community Clinical Oncology Program (CCOP) applicant institutions. An original research base serving the CCOP program since 1983, the URCC has evolved and developed considerable resources for cancer control research activities. This competing renewal focuses on strengths in the development and implementation of cancer control studies resulting from being a clinical cancer center research base exclusively for cancer control research. The URCC CCOP Research Base is committed to a process and climate that fosters protocol development through collaboration among member CCOPs and affiliates, experienced cancer control experts at our research base and consultants in cancer control areas. The beginning success of this is shown through the fact that 13 of our 23 CCOPs/MBCCOPS have proposed a concept that has been submitted to NCI. CCOP members and affiliates have proposed 16 cancer control concepts, six of which have been developed into protocols. Further, all of our currently active protocols are chaired or co-chaired by CCOP/MBCCOP investigators. Over the past five years, 2553 participants (representing 2553 credits) have been entered on URCC protocols. The URCC Research Base had a total of 12 cancer control protocols open, six of which are now closed, leaving a total of six currently active cancer control protocols. During this renewal period, we added five new CCOPs for a total of 20 CCOPs and three minority-based CCOPs within the URCC network.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA037420-29
Application #
8537824
Study Section
Special Emphasis Panel (ZCA1-SRRB-Y (J1))
Program Officer
O'Mara, Ann M
Project Start
1983-09-30
Project End
2014-05-31
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
29
Fiscal Year
2013
Total Cost
$2,114,386
Indirect Cost
$796,683
Name
University of Rochester
Department
Internal Medicine/Medicine
Type
Schools of Dentistry
DUNS #
041294109
City
Rochester
State
NY
Country
United States
Zip Code
14627
Janelsins, Michelle C; Kesler, Shelli R; Ahles, Tim A et al. (2014) Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry 26:102-13
TreviƱo, Lara A; Baker, Liana; McIntosh, Scott et al. (2014) Physical activity as a coping strategy for smoking cessation in mid-life and older adults. Addict Behav 39:885-8
Devine, Katie A; Heckler, Charles E; Katz, Ernest R et al. (2014) Evaluation of the psychometric properties of the Pediatric Parenting Stress Inventory (PPSI). Health Psychol 33:130-8
Kamen, Charles; Tejani, Mohamedtaki A; Chandwani, Kavita et al. (2014) Anticipatory nausea and vomiting due to chemotherapy. Eur J Pharmacol 722:172-9
Peppone, Luke J; Mustian, Karen M; Rosier, Randy N et al. (2014) Bone health issues in breast cancer survivors: a Medicare Current Beneficiary Survey (MCBS) study. Support Care Cancer 22:245-51
Gewandter, Jennifer S; Mohile, Supriya G; Heckler, Charles E et al. (2014) A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors. Support Care Cancer 22:1807-14
Chandwani, Kavita D; Heckler, Charles E; Mohile, Supriya G et al. (2014) Hot flashes severity, complementary and alternative medicine use, and self-rated health in women with breast cancer. Explore (NY) 10:241-7
Mustian, Karen M; Sprod, Lisa K; Janelsins, Michelle et al. (2013) Multicenter, randomized controlled trial of yoga for sleep quality among cancer survivors. J Clin Oncol 31:3233-41
Gewandter, J S; Fan, L; Magnuson, A et al. (2013) Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study. Support Care Cancer 21:2059-66
Kirshner, Jeffrey J; Heckler, Charles E; Janelsins, Michelle C et al. (2012) Prevention of pegfilgrastim-induced bone pain: a phase III double-blind placebo-controlled randomized clinical trial of the university of rochester cancer center clinical community oncology program research base. J Clin Oncol 30:1974-9

Showing the most recent 10 out of 55 publications